Columnist: Stem Cell Agency Must Make Key Changes
Los Angeles Times columnist Michael Hiltzik argues that the California Institute for Regenerative Medicine's governing board "can't dodge" the Institute of Medicine's recent recommendations "for changes in its membership and its authority over the spending of its $3-billion endowment." The report "showed CIRM the path to cleansing itself of its aura of connivance and influence trading," Hiltzik writes, concluding, "That the board can't even bring itself to place the proposals before the voters or their elected representatives only shows how much money it's willing to waste to keep living in its own little world."
- "Stem Cell Agency Not Doing Enough To Avoid Conflict of Interest" (Hiltzik, Los Angeles Times, 1/29).